The Korean Journal of Pain

The Korean Pain Society (대한통증학회)
권호 표지
DOI QR코드

DOI QR Code

Relief of Postherpetic Neuralgia with Transforaminal Epidural Injection of Magnesium -A Case Report-

  • Yu, Ho-Kyoung (Department of Anesthesiology and Pain Medicine, Bucheon Hospital, College of Medicine, Soonchunhyang University) ;
  • Lee, Joon-Ho (Department of Anesthesiology and Pain Medicine, Bucheon Hospital, College of Medicine, Soonchunhyang University) ;
  • Cho, Sung-Hwan (Department of Anesthesiology and Pain Medicine, Bucheon Hospital, College of Medicine, Soonchunhyang University) ;
  • Kim, Yong-Ik (Department of Anesthesiology and Pain Medicine, Bucheon Hospital, College of Medicine, Soonchunhyang University)
  • Received : 2010.12.14
  • Accepted : 2011.01.21
  • Published : 2011.03.01
Download PDF
⟨ Previous Next ⟩

Abstract

Although postherpetic neuralgia (PHN) is a common chronic pain syndrome, the pathophysiology of this disorder is not well known and management is often very difficult. N-methyl-D-Aspartate (NMDA) receptor antagonists are known to be effective in PHN, and magnesium, a physiological blocker of NMDA receptors, is widely used to treat various chronic pain disorders. Here, we present a case of the PHN refractory to conventional treatment, which was treated successfully with transforaminal epidural injection of magnesium sulphate at the affected dermatome.

Keywords

References

  1. Loeser JD. Herpes zoster and postherpetic neuralgia. Pain 1986; 25: 149-64. https://doi.org/10.1016/0304-3959(86)90089-8
  2. Kost RG, Straus SE. Postherpetic neuralgia--pathogenesis, treatment, and prevention. N Engl J Med 1996; 335: 32-42. https://doi.org/10.1056/NEJM199607043350107
  3. Eide PK, Jorum E, Stubhaug A, Bremnes J, Breivik H. Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, crossover comparison with morphine and placebo. Pain 1994; 58: 347-54. https://doi.org/10.1016/0304-3959(94)90129-5
  4. Arcioni R, Palmisani S, Tigano S, Santorsola C, Sauli V, Romano S, et al. Combined intrathecal and epidural magnesium sulfate supplementation of spinal anesthesia to reduce post-operative analgesic requirements: a prospective, randomized, double- blind, controlled trial in patients undergoing major orthopedic surgery. Acta Anaesthesiol Scand 2007; 51: 482-9. https://doi.org/10.1111/j.1399-6576.2007.01263.x
  5. Eide PK, Stubhaug A, Stenehjem AE. Central dysesthesia pain after traumatic spinal cord injury is dependent on N-methyl-D-aspartate receptor activation. Neurosurgery 1995; 37: 1080-7. https://doi.org/10.1227/00006123-199512000-00007
  6. Crosby V, Wilcock A, Corcoran R. The safety and efficacy of a single dose (500 mg or 1 g) of intravenous magnesium sulfate in neuropathic pain poorly responsive to strong opioid analgesics in patients with cancer. J Pain Symptom Manage 2000; 19: 35-9. https://doi.org/10.1016/S0885-3924(99)00135-9
  7. Brill S, Sedgwick PM, Hamann W, Di Vadi PP. Efficacy of intravenous magnesium in neuropathic pain. Br J Anaesth 2002; 89: 711-4. https://doi.org/10.1093/bja/89.5.711
  8. Demirkaya S, Vural O, Dora B, Topcuoglu MA. Efficacy of intravenous magnesium sulfate in the treatment of acute migraine attacks. Headache 2001; 41: 171-7. https://doi.org/10.1046/j.1526-4610.2001.111006171.x
  9. Collins S, Zuurmond WW, de Lange JJ, van Hilten BJ, Perez RS. Intravenous magnesium for complex regional pain syndrome type 1 (CRPS 1) patients: a pilot study. Pain Med 2009; 10: 930-40. https://doi.org/10.1111/j.1526-4637.2009.00639.x
  10. Oppelt WW, MacIntyre I, Rall DP. Magnesium exchange between blood and cerebrospinal fluid. Am J Physiol 1963; 205: 959-62.
  11. Felsby S, Nielsen J, Arendt-Nielsen L, Jensen TS. NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride. Pain 1996; 64: 283-91. https://doi.org/10.1016/0304-3959(95)00113-1
  12. Ko SH, Lim HR, Kim DC, Han YJ, Choe H, Song HS. Magnesium sulfate does not reduce postoperative analgesic requirements. Anesthesiology 2001; 95: 640-6. https://doi.org/10.1097/00000542-200109000-00016
  13. Saeki H, Matsumoto M, Kaneko S, Tsuruta S, Cui YJ, Ohtake K, et al. Is intrathecal magnesium sulfate safe and protective against ischemic spinal cord injury in rabbits? Anesth Analg 2004; 99: 1805-12.
  14. Chanimov M, Cohen ML, Grinspun Y, Herbert M, Reif R, Kaufman I, et al. Neurotoxicity after spinal anaesthesia induced by serial intrathecal injections of magnesium sulphate. An experimental study in a rat model. Anaesthesia 1997; 52: 223-8. https://doi.org/10.1111/j.1365-2044.1997.034-az0057.x
  15. Bilir A, Gulec S, Erkan A, Ozcelik A. Epidural magnesium reduces postoperative analgesic requirement. Br J Anaesth 2007; 98: 519-23. https://doi.org/10.1093/bja/aem029
  16. Farouk S. Pre-incisional epidural magnesium provides pre-emptive and preventive analgesia in patients undergoing abdominal hysterectomy. Br J Anaesth 2008; 101: 694-9. https://doi.org/10.1093/bja/aen274
  17. Buvanendran A, McCarthy RJ, Kroin JS, Leong W, Perry P, Tuman KJ. Intrathecal magnesium prolongs fentanyl analgesia: a prospective, randomized, controlled trial. Anesth Analg 2002; 95: 661-6.

Cited by

  1. Medications in Treatment of Postherpetic Neuralgia vol.27, pp.1, 2014, https://doi.org/10.3344/kjp.2014.27.1.1
  2. Magnesium and Pain vol.12, pp.8, 2011, https://doi.org/10.3390/nu12082184